Delivery Order SPE2DB25D9237-SPE2DB25FTFQR
Award Date
6/13/25
Potential Completion Date
7/8/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,165.86 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has a completion date of June 6, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in providing a comprehensive range of medical products, including branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $6,837.40 and a period of performance through May 8, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999, which allows the DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The contract, with a potential value of $10,720.35, has a completion date of February 28, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic pharmaceutical products to U.S. government agencies,...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NEXPLANON 68 MG IMPLANTS. The $5,717.52 contract has a completion date of March 7, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical and medical products to federal agencies, particularly the Department of Veterans Affairs and Department of...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the delivery of 4,564,287,718 units of NEXPLANON 68 MG IMPLANTS. This Delivery Order is part of a larger Indefinite Delivery Vehicle (IDV) contract, valued at up to $4,999,999, that enables DLA to issue orders for a broad range of pharmaceutical items to support military health...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,429.38 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, with a period of performance through May 2, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. The $8,576.28 contract has a completion date of March 22, 2024 and is part of DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with DLA, valued at up to $4,999,999 through 2025, to provide a broad range of pharmaceutical products to military health facilities. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $7,146.90 contract is for the supply of NEXPLANON 68 MG IMPLANTS to support the recurring medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The Defense Logistics Agency (DLA) awarded a $3,573.45 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a $3,471.55 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of April 14, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...